NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Codexis Inc. (LSE: 0I0X)

 
0I0X Technical Analysis
5
As on 7th Nov 2025 0I0X STOCK Price closed @ 1.66 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.52 & Strong Sell for SHORT-TERM with Stoploss of 3.23 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

0I0XSTOCK Price

Open 1.79 Change Price %
High 1.79 1 Day -0.41 -19.81
Low 1.61 1 Week -0.78 -31.97
Close 1.66 1 Month -0.73 -30.54
Volume 16844 1 Year -1.49 -47.30
52 Week High 5.98 | 52 Week Low 2.00
 
LSE UK Most Active Stocks
ORCP 0.04 0.00%
UKOG 0.01 0.00%
ALBA 0.02 0.00%
TRP 0.03 0.00%
CPX 0.28 -12.50%
DEMG 0.02 -50.00%
MSMN 0.03 50.00%
MIRI 0.01 0.00%
SYME 0.00 %
SMDS 582.50 0.00%
 
LSE UK Top Gainers Stocks
BIOM 7.78 937.33%
0YY7 20.40 280.60%
0VSO 35.60 228.41%
SSIF 18.50 208.33%
CGW 55.03 107.66%
0QWC 20.60 101.37%
GILD 0.08 100.00%
GILD 0.08 100.00%
GILD 0.08 100.00%
0QTF 0.17 88.89%
 
LSE UK Top Losers Stocks
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
JPE 12.55 -98.66%
SPPC 0.15 -93.75%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
0IHM 30.73 -79.82%
 
 
0I0X
Daily Charts
0I0X
Intraday Charts
Whats New @
Bazaartrend
0I0X
Free Analysis
 
0I0X Important Levels Intraday
RESISTANCE2.01
RESISTANCE1.90
RESISTANCE1.83
RESISTANCE1.76
SUPPORT1.56
SUPPORT1.49
SUPPORT1.42
SUPPORT1.31
 
0I0X Forecast November 2025
4th UP Forecast3.72
3rd UP Forecast3.06
2nd UP Forecast2.65
1st UP Forecast2.24
1st DOWN Forecast1.08
2nd DOWN Forecast0.67
3rd DOWN Forecast0.26
4th DOWN Forecast-0.4
 
0I0X Weekly Forecast
4th UP Forecast3.03
3rd UP Forecast2.59
2nd UP Forecast2.32
1st UP Forecast2.05
1st DOWN Forecast1.27
2nd DOWN Forecast1.00
3rd DOWN Forecast0.73
4th DOWN Forecast0.29
 
0I0X Forecast2025
4th UP Forecast10.22
3rd UP Forecast7.47
2nd UP Forecast5.78
1st UP Forecast4.08
1st DOWN Forecast-0.76
2nd DOWN Forecast-2.46
3rd DOWN Forecast-4.15
4th DOWN Forecast-6.9
 
Codexis Inc. ( LSE UK Symbol : 0I0X )
Sector : N/A And Other Stocks in Same Sector
 
0I0X Other Details
Segment EQ
Market Capital 1533216640.00
Sector
Industry
Offical website >
 
0I0X Address
0I0X
 
0I0X Latest News
 
Your Comments and Response on Codexis Inc.
 
0I0X Business Profile
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California. Address: 200 Penobscot Drive, Redwood City, CA, United States, 94063
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service